Defendant

Gland Pharma Limited

1 case as defendant.

Cases
1
Active
0
1 closed
Filed
2022
Top venue
D. New Jersey
1 case

Helsinn Healthcare S.A. v. Gland Pharma Limited

consent judgment and dismissal
Docket:
3:22-cv-04635
Filed:
2022-07-18
Terminated:
2023-01-19
Patents:108282978426450889558691863579403772990890710208073106249111071772111312698
π Helsinn Healthcare S.A.Δ Gland Pharma Limited

Helsinn sued Gland under the Hatch-Waxman Act over Gland's ANDA No. 217374 for generic fosnetupitant/palonosetron IV product, asserting ten patents including U.S. 10,828,297; the action was also cited in some sources as 2:22-cv-04635. It was resolved by consent judgment and dismissal order in January 2023, with Gland admitting technical infringement under 35 U.S.C. § 271(e)(2)(A) and enjoined from marketing the ANDA product until a redacted date; Gland's invalidity/non-infringement counterclaims were not adjudicated.